Fact checked by Nick Blackmer The Food and Drug Administration (FDA) has expanded its approval of a ketamine nasal spray, Spravato (esketamine), as a standalone therapy for adults with treatment ...

RISE Integrated Mental Health in York, Maine, offers ketamine therapy for trauma and depression, attracting patients ...

Also, Spravato isn’t approved for anesthetic purposes like ketamine. (An anesthetic causes a loss of sensation, such as during surgery.) In studies , Spravato wasn’t proven to be safe and ...

Spravato is the first ketamine-based medicine approved to treat depression, and also the first of a new class of glutamate NMDA receptor-targeting drugs that have ended a decades-long drought at ...

In 2019, the U.S. Food and Drug Administration (FDA) approved a derivative of ketamine in a nasal spray format (Spravato, or S-ketamine) for treatment-resistant depression and suicidal ideation.

When Matt Thierfelder began his career as a Vancouver firefighter in 1994, the weight of unspoken rules hung over him: Don’t show weakness and don’t be vulnerable.

To treat my drug-resistant depression, a psychiatrist prescribed Spravato, an FDA-approved version of ketamine. On one trip, my dead grandpa talked with me. I looked at my hands once.

A ketamine derivative, esketamine under the brand name Spravato, is FDA-approved as a nasal spray to treat depression in adults, according to the National Institute on Drug Abuse.

Medicare does not typically cover ketamine infusions for mental health conditions, but may cover Spravato, a Food and Drug Administration (FDA)-approved drug derived from ketamine and used for ...

There are two main forms of ketamine treatment administered by clinics: IV ketamine infusion and Spravato, a ketamine-derived nasal spray used to treat depression. Keta Medical Center.

Medicare does not typically cover ketamine infusions for mental health conditions, but may cover Spravato, a Food and Drug Administration (FDA)-approved drug derived from ketamine and used for ...